TNFRSF1A and arthritic joint disease: Although arthritis progression was inhibited in all groups, the arthritis was completely resolved in 43% of mice given the combined treatment, as compared to 4% and 13% of mice given DX‐2400 and TNFR‐Fc alone, respectively.